FindTrial
Sign In

A clinical trial to study the effect of Rasagandhi mezhugu for Karuppai Sathai Kattigal(Fibroid Uterus)

Clinical trial of Rasagandhi mezhugu in Karuppai Sathai Kattigal(Fibroid Uterus)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014338
Enrollment
20
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Karuppai Sathai kattigal(Fibroid uterus) Health Condition 2: D259- Leiomyoma of uterus, unspecified

Interventions

Intervention1: Rasagandhi mezhugu capsule: 500mg twice daily for 45 days Control Intervention1: Not applicable: 0

Sponsors

Central Council for Research in Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical signs and symptoms of fibroid uterus for more than 6 months Presence of fibroid,confirmed by TV Sonography

Exclusion criteria

Exclusion criteria: Malignancy Metabolic disorder-DM/CVD/HT/PT HIV/AIDS Chromosomal abnormality

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Rasagandhi mezhugu in the treatment of Karuppai Sathai kattigal with the reduction in size/no,of fibroids and disappearance of fibroids after 3 months of treatment and the biochemical parameters were also analysed.Timepoint: The outcome of the trial is assessed after 3 months of study period.—

Secondary

MeasureTime frame
To evaluate the safety of Rasagandhi mezhugu and to improve the QOL.Timepoint: 90 days—

Countries

India

Contacts

Public ContactDr Shyamala Rajkumar

Siddha Regional Research Institute

rrisiddha@yahoo.co.in04132245072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026